Does cryotherapy affect refractive error? Results from treated versus control eyes in the cryotherapy for retinopathy of prematurity trial
- PMID: 11158812
- DOI: 10.1016/s0161-6420(00)00527-3
Does cryotherapy affect refractive error? Results from treated versus control eyes in the cryotherapy for retinopathy of prematurity trial
Abstract
Purpose: To evaluate the effect of cryotherapy on refractive error status between ages 3 months and 10 years in children with birth weights of less than 1251 g in whom severe retinopathy of prematurity (ROP) developed in one or both eyes during the neonatal period.
Design: Randomized clinical trial.
Participants: Two hundred ninety-one children in whom severe ROP developed during the neonatal period.
Intervention: Cryotherapy for ROP.
Main outcome measures: Cycloplegic Refraction
Methods: The children underwent repeated follow-up eye examinations, including cycloplegic retinoscopy, between 3 months and 10 years after term due date. Refractive error data from all eyes that were randomized to cryotherapy were compared with data from all eyes that were randomized to serve as controls. Refractive error data were also compared for a subset of children who had both a treated and a control eye that could be refracted.
Results: At all ages, the proportion of treated eyes that were unable to be refracted because of retinal detachment, media opacity, or pupillary miosis was approximately half the proportion of the control eyes that were unable to be refracted. When data from all eyes that could be refracted were considered, the distribution of refractive errors between fewer than 8 diopters (D) of myopia and more than 8 D of hyperopia was similar for treated and control eyes at all ages. The proportion of eyes with 8 D or more of myopia was much higher in treated than in control eyes at all ages after 3 months. In the subset of children who had a treated eye and a control eye that could be refracted, distributions of refractive errors in treated versus control eyes were similar at most ages.
Conclusions: In both treated and control eyes, there was an increase in the prevalence of high myopia between 3 and 12 months of age. Between 12 months and 10 years of age, there was little change in distribution of refractive error in treated or control eyes. The higher prevalence of myopia of 8 D or more in treated eyes, as compared with control eyes, may be the result of cryotherapy's preservation of retinal structure in eyes that, in the absence of cryotherapy, would have progressed to retinal detachment.
Similar articles
-
Prevalence of myopia between 3 months and 5 1/2 years in preterm infants with and without retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group.Ophthalmology. 1998 Jul;105(7):1292-300. doi: 10.1016/s0161-6420(98)97036-1. Ophthalmology. 1998. PMID: 9663236
-
Development of myopia in infants with birth weights less than 1251 grams. The Cryotherapy for Retinopathy of Prematurity Cooperative Group.Ophthalmology. 1992 Mar;99(3):329-40. doi: 10.1016/s0161-6420(92)31968-2. Ophthalmology. 1992. PMID: 1565444 Clinical Trial.
-
Progression of myopia and high myopia in the early treatment for retinopathy of prematurity study: findings to 3 years of age.Ophthalmology. 2008 Jun;115(6):1058-1064.e1. doi: 10.1016/j.ophtha.2007.07.028. Ophthalmology. 2008. PMID: 18423871 Clinical Trial.
-
Ocular sequelae in premature infants.Pediatrics. 1993 Dec;92(6):787-90. Pediatrics. 1993. PMID: 8233737 Review.
-
Refractive status, biometric components, and functional outcomes of patients with threshold retinopathy of prematurity: systemic review and a 17-year longitudinal study.Graefes Arch Clin Exp Ophthalmol. 2022 Dec;260(12):3809-3816. doi: 10.1007/s00417-022-05730-6. Epub 2022 Jun 22. Graefes Arch Clin Exp Ophthalmol. 2022. PMID: 35729410
Cited by
-
Progression of myopia and high myopia in the Early Treatment for Retinopathy of Prematurity study: findings at 4 to 6 years of age.J AAPOS. 2013 Apr;17(2):124-8. doi: 10.1016/j.jaapos.2012.10.025. J AAPOS. 2013. PMID: 23622444 Free PMC article. Clinical Trial.
-
Change of refractive state and eye size in children of birth weight less than 1701 g.Br J Ophthalmol. 2006 Apr;90(4):456-60. doi: 10.1136/bjo.2005.083535. Br J Ophthalmol. 2006. PMID: 16547327 Free PMC article.
-
Association between myopia progression and quantity of laser treatment for retinopathy of prematurity.PLoS One. 2022 Dec 30;17(12):e0279898. doi: 10.1371/journal.pone.0279898. eCollection 2022. PLoS One. 2022. PMID: 36584135 Free PMC article.
-
Refractive outcomes of three-port lens-sparing vitrectomy for retinopathy of prematurity (An AOS Thesis).Trans Am Ophthalmol Soc. 2009 Dec;107:300-10. Trans Am Ophthalmol Soc. 2009. PMID: 20126504 Free PMC article.
-
[Long-term effects of anti-VEGF therapy for retinopathy of prematurity].Ophthalmologe. 2018 Jun;115(6):464-468. doi: 10.1007/s00347-018-0700-6. Ophthalmologe. 2018. PMID: 29654389 Review. German.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources